The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

BACKGROUND: OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-responders b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Headache Pain
Main Authors: Matharu, Manjit, Halker, Rashmi, Pozo-Rosich, Patricia, DeGryse, Ronald, Manack Adams, Aubrey, Aurora, Sheena K.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Milan 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5539058/
https://ncbi.nlm.nih.gov/pubmed/28766236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-017-0784-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker